OUR PRODUCTS

MOBILE APPS

GENERAL INFO

AVBP

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

ArriVent BioPharma (AVBP) Earnings Date & Reports

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AVBP is expected to report earnings to fall 12.22% to -79 cents per share on November 13

ArriVent BioPharma AVBP Stock Earnings Reports

Q3'25

Est.

$-0.79

Q2'25

Missed

by $0.14

Q1'25

Missed

by $1.17

Q4'24

Missed

by $0.14

Q3'24

Missed

by $0.07

The last earnings report on August 11 showed earnings per share of -89 cents, missing the estimate of -75 cents. With 274.80K shares outstanding, the current market capitalization sits at 792.31M.

View a ticker or compare two or three

Compare

AVBP

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AVBP
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AVBP showed earnings on August 11, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

18 Campus Boulevard

Phone

+1 628 277-4836

Employees

Web

https://arrivent.com